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Abstract 
Purpose: To investigate the hypocholesterolemic and hepatoprotective effects of Olea europaea Linn. 
(Oleaceae) fruit pulp (OFP-EA) extract in experimental rats.  
Methods: Sprague–Dawley rats were fed with a normal diet, a high-cholesterol diet or high-cholesterol 
diets supplemented with OFP-EA extract (100 or 300 mg/kg/day p.o.) for 28 days. Plasma lipid profile 
such as total cholesterol (TC), triglycerides (TG), high-density lipoprotein (HDL) and low-density 
lipoprotein (LDL) were measured using their respective commercial kits. Gross appearance and lipid 
content of liver samples were also analyzed. The changes in protein expressions of key enzymes such 
as hydroxymethylglutaryl-CoA reductase (HMGR), acyl-CoA:cholesterol acyltransferase (ACAT), 
cytochrome P450 7A1 (CYP7A1) and peroxisome proliferation-activated receptor alpha (PPAR-α) in rat 
livers were evaluated using Western blotting.  
Results: OFP-EA-extract markedly altered the increased plasma TC, TG, LDL and decreased the HDL 
induced by a hypercholesterolemic diet with a dose-dependent improvement on both atherogenic index 
and cardiac risk factor (p < 0.01 and p < 0.001 at 100 and 300 mg/kg dose, respectively). Lipid 
deposition in liver was attenuated significantly in hypercholesterolemic animals supplemented with OFP-
EA-extract (p < 0.01 at 100 and p < 0.001 at 300 mg/kg dose, respectively). Further mechanistic studies 
revealed that OFP-EA extract regulated the altered expressional levels of CYP7A1 and PPAR-α in the 
livers of hypercholesterolemic diet-induced rats.  
Conclusion: The hypocholesterolemic and hepatoprotective functions of OFP-EA-extract are probably 
due to the increase in fatty acids unitization in liver via the up-regulation of PPAR-α level.  
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Olea europaea Linn. from the family, Oleaceae, 
commonly known as olive is among the oldest 
known cultivated trees in the world with immense 
medicinal values. The beneficial effects of a 
Mediterranean diet rich in olive oil and table 
olives have been widely reported [1,2]. Olive 
products are rich in natural antioxidants that may 
inhibit oxidative stress during the development of 
major diseases such as coronary heart disease 
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[3,4], cancer [5] and neurodegenerative diseases 
[6]. The antioxidant properties of olive products 
have been attributed to the presence of phenolic 
compounds [7] which act by scavenging free 
radicals and chelating metallic ions [1]. After the 
extraction of oil from the olive, many phenolic 
compounds remain in the by-products. Olive-mill 
waste water known as “alpechin” and olive oil 
cake known as “alperujo” contain a similar 
phenolic profile to that of the original fruit [8]. 
Earlier studies reported by our group on olive 
fruit pulp ethyl acetate (OFP-EA) extract revealed 
a strong anti-oxidant and anti-neuroinflammatory 
properties [6]. In the present study we 
investigated the hypocholesterolemic and 
hepatoprotective effects OFP-EA extract in 
normal and hypocholesterolemic-induced 
experimental rats.  
 
Cardiovascular disease (CVD) is a leading cause 
of death and its incidence rate is increasing day 
by day in the developing world. Although the 
progression of CVD is multifactorial, modern 
lifestyle with high-cholesterol diet and less 
physical activity contributes to 
hypercholesterolemia which is believed to play 
an important role in the pathogenesis and 
progression of CVD [9, 10]. In addition, 
hypercholesterolemia can result in non-alcoholic 
fatty liver disease (NAFLD), which is a 
pathological condition of emerging clinical 
importance and considered as the most common 
cause of abnormal liver function [11]. NAFLD is 
characterized by a wide spectrum of liver 
damage, such as simple steatosis, fibrosis and 
cryptogenic cirrhosis [11]. The progression of the 
disease involves increased inflammation and 
oxidative stress leading to lipid peroxidation [12]. 
Thus, controlling plasma cholesterol or 
preventing hypercholesterolemia is an ideal 
approach to control the development of CVD and 
NAFLD. Although several drugs are available 
clinically, researches have focused on the 
consumption of anti-oxidant rich dietary 
supplements and functional foods from natural 
herbs in lowering and/or controlling 
hypercholesterolemia and NAFLD. [13].  
 
Therefore, we investigated the effects of OFP-EA 
extract on normal and high fat diet (HFD) fed rats 
and evaluated the plasma lipid profiles such as 
triglycerides (TG), total cholesterol (TC), high-
density lipoprotein (HDL) and low-density 
lipoprotein (LDL)] in the liver. Further, the 
atherogenic index, cardiac risk factor, total lipid 
level and the changes in the protein expressions 
of key enzymes such as hydroxymethylglutaryl-
CoA reductase (HMGR), acyl-CoA:cholesterol 
acyltransferase (ACAT), cytochrome P450 7A1 
(CYP7A1) and peroxisome proliferation-activated 
receptor alpha (PPAR-α), responsible for the 
cholesterol homeostasis were studied in the 
livers so as to understand its effect on hepatic 






Dulbecco's modified Eagle medium (DMEM), 
fetal bovine serum (FBS), and penicillin were 
purchased from HyClone Laboratories, Inc. 
(South Logan, Utah). The kits for analyzing 
plasma lipid profile were purchased from Asan 
Biotech. Co. Ltd. (Seoul, Korea). All other 
reagents are of highest grade commercially 
available.   
 
Preparation of OFP-EA extract  
 
The OFP-EA extract was prepared as described 
in our earlier published work [6] . Briefly, Green 
olive fruits collected at the end of September to 
about the middle of November were obtained 
from the local market, Seoul, South Korea. The 
collected fruit material was authenticated by Prof 
Jong-Bo Kim, a taxonomist at Konkuk University, 
Korea and a voucher specimen (OL-KU2012) 
has been kept in our laboratory herbarium, 
Konkuk University, Korea for future reference. To 
obtain the olive fruit pulp extract, 500 g of the 
fruit were ground in a mixer and defatted three 
times with three volumes of 80% ethanol. The 
residue (fruit pulp) was extracted with absolute 
ethanol (EtOH) at 1:10 ratio (w/v) for 2 h in a 
heating mantle at 70 - 80 °C. The supernatant 
was filtered and concentrated in a rotatory 
evaporator at 50 °C. The ethanol extract of olive 
fruit pulp obtained (180 g) was re-suspended in 
water:EtOH (9:1, v/v) and partitioned 
successively with n-hexane, ethyl acetate (EA) 
and n-butanol to obtain a final yield of 19.4, 52 
and 27.27 %, respectively. EA extract was 
dissolved in sterile distilled water and filtered on 
0.22 μm filter before use.  
 
HPLC finger print analysis of OFP-EA extract 
 
A Shimadz system equipped with binary pumps, 
an inline degasser, an autosampler, and a PAD 
detector was used. UV spectra were recorded 
between 200 and 450 nm and the UV trace was 
measured at 360 nm. A Symmetry C18 analytical 
column (250 ´ 4.6 mm i.d.; particle size, 5 µm) 
fitted with a Novapack RP C18 guard column 
(Waters, Millford, MA) were used for the 
separation. The mobile phase consisted of 0.5 % 
formic acid in deionized water (A) and 0.5 % 
formic acid in acetonitrile:methanol (50:50, v/v) 
(B). The gradient program was as follows: 25 % 
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B to 40 % B in 20 min, 40 % B to 50 % B in 5 
min, 50 % to 100 % B in 5 min followed by 100 % 
B in 5 min at a flow rate of 1 mL min-1. There 
was a 10-min post-run going back to the starting 
conditions for reconditioning. The column oven 
temperature was kept at 40 ºC. The injection 
volume was 10 µL.  
 
Animals and experimental treatment 
 
Male Sprague–Dawley rats (~250 g, 2 months 
old) were obtained from Nara Bio Co. (Seoul, 
Korea). Rats were housed separately (four 
animals per cage) under a temperature-
controlled room (25 ± 2 °C, humidity 55 %, 12 h-
light/dark cycle) and provided free access to 
water and food. After 1 week, the rats were 
randomly assigned to one of four experimental 
groups (n = 10) for an additional 28 days. These 
groups were the control group, the HFD group, 
the low-dose OFP-EA-extract (100 mg/kg/day 
p.o.) treated group and the high-dose OFP-EA-
extract (300 mg/kg/day p.o.) treated group. The 
control group was fed with standard normal rat 
chow with protein (~14 %), fat (~10 %) and 
carbohydrate (~76 %), whereas the other groups 
were fed with HFD, which is a standard rat chow 
supplemented with 1 % cholic acid, 2 % pure 
cholesterol and 5.5 % oil. The rats were 
administered with distilled water or OFP-EA 
extract (100 and 300 mg/kg) by oral gavage (20 
mL/kg) once every morning for 28 days. At the 
end of the experimental period, the rats were 
fasted overnight and sacrificed by cervical 
dislocation. Blood samples and liver tissues were 
then collected for further analysis. All 
experiments were performed under the 
guidelines of Principles of Laboratory Animal 
Care (NIH publication No. 85-23, revised 1985) 
and our Institutional Animal Care and Use 
Committee, Konkuk University. 
 
Analysis of lipid levels in blood samples 
 
To obtain the baseline lipid profiles in plasma, 
fasted blood samples (2 mL) were collected from 
the right orbital sinus of rats anesthetized with 
diethyl ether through a small heparinized 
capillary tube before the experiment. After the 
28-day treatment period, rats were sacrificed by 
cervical dislocation. Fasted blood samples (2 
mL) were collected in chilled heparinized 
centrifuge tubes by cardiac puncture with 
heparinized syringes. The blood samples were 
centrifuged (1500 x g) at 4 °C for 15 min. The 
collected plasma samples were stored at −80 °C 
until further analysis. Plasma levels of TC, TG, 
LDL and HDL were measured by using the Asan 
Biotech (Seoul, Korea).  
 
Gross appearance and lipid content of liver 
 
At the end of the study, the whole liver was 
harvested from rats and rinsed in saline (three to 
four times) to remove as much blood as possible. 
The gross appearance of livers of individual rat 
was photographed for comparison. The sample 
of liver (~2 g) was dissected and homogenized 
with 2:1 chloroform–methanol mixture (v/v) to a 
final dilution of 1:20 w/v using Ultra-turrax T-25 
homogenizer. After filtration, 10 mL of filtrate was 
added to 2 mL water, and the mixture was 
centrifuged at 900 g for 20 min. The lower phase 
was dried, and its weight was measured. Liver 
lipid content was expressed as weight of lipid per 
gram of liver. 
 
Western blot analysis  
 
Hepatic HMGR, ACAT, CYP7A1 and PPAR-α 
protein levels were quantified using western 
blotting procedures. Liver tissues from various 
experimental groups were isolated (∼1 g), 
weighed and kept at −80 °C immediately until 
homogenization procedures. Each frozen sample 
was homogenized on ice in lysis buffer consisting 
of 50 mM Tris-HCl (pH 8.0), 150 mM NaCl, 1 % 
Triton X-100, 0.5 % sodium deoxycholate, 0.1 % 
sodium dodecyl sulfate (SDS), 1 mM EDTA 
(Sigma), 1% protease inhibitor cocktail, and 1 % 
phosphatase inhibitor cocktail (Roche). After 
centrifugation, the protein concentration of the 
supernatant was assayed using a Bio-Rad DC 
Protein Assay kit. Lysate samples (containing 20 
µg for HMGR and ACAT; 40 µg for CYP7A1 and 
PPAR-α) of protein were fractionated by SDS-10 
% polyacrylamide gel electrophoresis and then 
electroblotted onto polyvinylidene difluoride 
membranes (Millipore, Bedford, MA, USA). The 
membranes were probed with primary antibodies 
to anti-HMGR, anti-ACAT, anti-CYP7A1 
(1:1000), anti-β-actin (1:2000), and anti-PPAR 
(1:500). The blots were visualized by a 
PowerOpti-ECL (Animal Genetics Inc, 
Tallahassee, FL, USA) detection system 
according to the manufacturer’s procedure and 
the antibody-specific bands were scanned by a 
Luminescent Analyzer, LAS-3000 and quantified 




Data were expressed as means ± SEM, and n 
denotes the number of replications for each data 
point. After validation of each parameter for 
homogeneity of variance, the differences 
between groups were assessed by one-way 
ANOVA using Statistical Package for the Social 
Sciences for Windows (version 12; SPSS Inc., 
Chicago, IL, USA). Post hoc testing was 
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performed for intergroup comparisons using the 
least significance difference test; p values less 





Identification of active constituent, 
hydroxytyrosol from OFP-EA extract 
 
The HPLC finger printing analysis of OFP-EA 
extract was shown in Fig. 1. Earlier studies 
indicated that olive fruit contains polyphenolic 
compound including oleuropein, hydroxytyrosol, 
tyrosol, 4- hydroxyphenyl acetic acid, 
protocatechuic acid, caffeic acid and p-coumaric 
acid [14,15].  Espeacially, hydroxytyrosol shows 
a broad spectrum of beneficial effects such as 
cancer chemoprevention, cardioprotection, skin 
photoprotection and anti-inflammatory activity 
[16]. Therefore, the major peaks obtained in our 
HPLC fingerprint analysis were compared with 
standard hydroxytyrosol. Hydroxytyrosol was 
identified by HPLC/UV analysis using retention 
times and absorption spectra in the 200 − 380 
nm range (Fig 1B).  
 
Plasma cholesterol and lipoprotein profiles 
 
The plasma lipid profiles (TC, TG, HDL and LDL) 
from various treatment groups of rats are 
summarized in Table 1. Elevated levels of TC 
and LDL with a decreased HDL were observed in 
rats fed with HFD. Treatment with OFP-EA-
extract (100 and 300 mg/kg) significantly 
suppressed the increased plasma TC and LDL 
induced by the HFD. OFP-EA-extract (300 
mg/kg/day) significantly reduced the plasma total 
cholesterol (4.81 ± 0.31 mM/L, p < 0.01) and LDL 
(6.92 ± 0.70 mM/L, p < 0.05), as compared with 
those in the HFD group (total cholesterol, 
5.67 ± 0.32 mM/L; LDL, 9.91 ± 1.25 mM/L). 
However, both the plasma total cholesterol and 
LDL contents did not return to normal level in the 
OFP-EA-extract (300 mg/kg/day) group. Animals 
treated with OFP-EA extract with HFD showed 
no significant change on the level of triglycerides. 
The level of HDL in the HFD was significantly 
lowered than that in the control group (p < 0.001). 
However treatment with OFP-EA-extract (300 
mg/kg/day) group (but not in the 100 mg/kg/day 
group), significantly enhanced the decreased 
plasma HDL as compared with the HFD group 
(p < 0.01). 
 
Fig 1: HPLC chromatogram of OFP-EA extract. A = 
identification of major peaks in OFP-EA extract. The 
arrow shown is the target compound, hydroxytyrosol; 
B = comparison with respective standard and structure 
of hydroxytyrosol. OFP-EA = Olea europea-ethyl 
acetate. 
 
Further, to evaluate the effect of plasma lipid 
profiles on the progression of atherosclerosis and 
 
Table 1: Plasma lipid levels of rats after administering 100 and 300 mg/kg doses, respectively  
 
Animal groups           Control        HFD         OFPEA-100     OFP-EA-300 
TC (mM)     Before     1.87 ± 0.13     2.23 ± 0.07      2.46 ± 0.10      2.27 ± 0.10  
              After      1.73 ± 0.07     5.67 ± 0.32###    5.45 ± 0.27###    4.81 ± 0.31###, *  
TG (mM)     Before    0.70 ± 0.01     0.71 ± 0.01      0.71 ± 0.01      0.70 ± 0.01  
              After      0.70 ± 0.01     0.68 ± 0.01      0.65 ± 0.01      0.61 ± 0.01  
LDL (mM)    Before     0.68 ± 0.03     0.81 ± 0.11      0.82 ± 0.08      0.92 ± 0.07  
              After      0.40 ± 0.04     9.91 ± 1.25###    8.74 ± 0.60###    6.92 ± 0.70###, *  
HDL (mM)    Before     0.94 ± 0.07     1.05 ± 0.02      1.10 ± 0.05      1.08 ± 0.05  
              After      0.91 ± 0.05    0.44 ± 0.04###    0.59 ± 0.05###   0.65 ± 0.07##, ** 
Data are expressed as mean ± SEM, n = 8–10. ##p < 0.01 and ###p < 0.001 when compared with the control group. * p < 0.05 and 
**p < 0.01 when compared with HFD group. Note:  TC = total cholesterol, TG = triglyceride, LDL = low density lipoprotein, HDL 
= high density lipoprotein. 
34 
Kim et al 





Fig 2: Effect of OFP-EA extract on atherogenic index 
and cardiac risk factor in HFD fed rats. The 
atherogenic index (A) and cardiac risk factor (B) of 
animals from the control, HFD, OFP-EA-extract (100 
mg/kg/day) and OFP-EA-extract (300 mg/kg/day) 
groups were shown. Data are expressed as 
mean ± SEM, n = 8–10. #p < 0.001 compared with the 
control group. **p < 0.01 and ***p < 0.001 when 
compared with the HFD fed group (HFD: high fat diet; 
OFP-EA: Olea europea-ethyl acetate)  
 
heart disease, the atherogenic index [(total 
serum cholesterol − HDL)/HDL] and the cardiac 
risk factor (total serum cholesterol/HDL) were 
measured, respectively (Fig 2). It was found that 
both the atherogenic index and the cardiac risk 
factor were elevated markedly in the HFD group. 
However, there was significant decrease in the 
atherogenic index (p < 0.01) and the cardiac risk 
factor (p < 0.01) in animals treated with OFP-EA-
extract (300 mg/kg/day) compared with the HFD 
group (Fig 2A and 2B). It suggested that OFP-EA 
treated at high doses (300 mg/kg) showed 
atheroscleroprotective and cardioprotective 
potential in the current experimental setting. 
 
Gross appearance and lipid content of liver 
 
The gross appearances of the rat livers from 
different treatment groups are depicted in the 
Fig 2B. The liver from the control group showed a 
relatively dark-red colour, whereas the liver from 
the HFD group showed a yellowish colour. In 
both OFP-EA-extract treated groups (100 and 
300 mg/kg dose), the isolated livers have a 
relatively lesser yellowish colour as compared 
with that from the HFD group. To evaluate the 
lipid content in the livers from different treatment 
groups, total lipid in the liver was isolated and 
compared. There was significant increase 
(p < 0.05) in liver lipid content in HFD group as 
compared with that of the control group. 
Interestingly, supplementing the animals with 100 
and 300 mg/kg/day of OFP-EA-extract could 
dose-dependently reduce the increased lipid 





Fig 3: Effect of OFP-EA extract on gross appearance 
and lipid content of liver (A) The gross appearance of 
the entire liver obtained from rats from the control, 
HFD, OFP-EA-extract (100 mg/kg/day) and OFP-EA-
extract(300 mg/kg/day) groups. (B) Total lipid content 
per gram of liver isolated from various indicated 
groups. Data are expressed as means ± SEM, n = 8–
10. #p < 0.001 compared with the control group. * 
p < 0.05 and **p < 0.01 when compared with the HFD 
fed group. HFD: high fat diet; OFP-EA: Olea europea-
ethyl acetate. (HFD: high fat diet; OFP-EA: Olea 
europea-ethyl acetate)  
 
Western blot results 
 
Molecular mechanisms of OFP-EA extract in the 
cholesterol metabolic pathway in liver were 
further studied by evaluating the changes in the 
protein expressional levels of hydroxymethyl-
glutaryl-CoA reductase (HMGR), acyl-. 
CoA:cholesterol acyltransferase (ACAT), 
cytochrome P450 7A1 (CYP7A1) and 
peroxisome proliferation-activated receptor alpha 
(PPAR-α) (Fig 4A). Quantification data revealed 
that the protein expression levels of HMGR in the 
livers from all the groups fed with HFD were 
markedly lower than that of the control group (Fig 
4B). Supplementing the hypercholesterolemic 
rats with OFP-EA extract at indicated doses (100 
and 300 mg/kg) showed no apparent change in 
the protein expression levels of HMGR. 
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However, the protein expressions of ACAT, 
CYP7A1 and PPAR-α in liver, were significantly 
increased in the HFD group as compared with 
that in the control group (p<0.001, Fig. 4B). 
Treatment with OFP-EA extract in 
hypercholesterolemic rats showed no apparent 
change in the protein expression level of ACAT. 
Interestingly, hypercholesterolemic rats treated 
with OFP-EA extract showed dose-dependent 
down-regulation in the protein expression of 
CYP7A1 and up-regulation in the protein 
expression of PPAR-α as compared with the 
HFD fed rats. 
 
 
Fig 4: Effect of OFP-EA extract on the protein 
expressions of HMGR, ACAT, CYP7A1 and PPAR-α 
in HFD fed rats. A: The protein expression of HMGR, 
ACAT, CYP7A1 and PPAR-α from isolated livers were 
evaluated by Western blotting. The expression level of 
each gene was normalized to that of the β-actin 
protein. B: The quantification data of each protein 
expression (HMGR, ACAT, CYP7A1 and PPAR-α) 
from the control, HFD, OFP-EA-extract(100 
mg/kg/day) and OFP-EA-extract(300 mg/kg/day) 
groups were shown. Data are expressed as 
means ± S.E.M, n = 8–10. #p < 0.001 compared with the 
control group. **p < 0.01 and ***p < 0.001 when 
compared with the HFD fed group. HFD: high fat diet; 
OFP-EA: Olea europea-ethyl acetate, HMGR: 
Hydroxymethylglutaryl-CoA reductase, ACAT: Acyl-
CoA:cholesterol acyltransferase, CYP7A1: 
Cytochrome P450 7A1, PPAR-α: Peroxisome 
proliferation-activated receptor alpha. HMGR/β-





Diet plays an important role in the regulation of 
cholesterol homeostasis. In recent decades, 
functional food and natural dietary substances 
from natural herbs possessing hypolipidemic and 
hypocholesterolemic properties have been 
extensively studied to determine their role in 
preventing CVD [17,18]. In this study, the effects 
of OFP-EA-extract on the plasma lipid profiles of 
HFD-fed rats were evaluated. Levels of TC and 
LDL were elevated, whereas HDL was lowered 
as a result of consuming HFD for 28 days. Our 
results are consistent with previous findings with 
similar experimental settings as there was no 
significant difference on plasma TG among 
various groups [18,19]. The supplementation of a 
high dose of OFP-EA extract (300 mg/kg) 
significantly altered the abnormal plasma lipid 
level induced by HFD. Reductions in the TC and 
LDL, but alleviation of HDL, were observed at the 
end of the 28-day treatment period. These 
results are in agreement with those reported in 
earlier studies with chlorogenic acid treatment in 
hypercholesterolemic animals [20,21]. Clinical 
and epidemiological studies have proved that 
people with elevated LDL have an increased risk 
for CVD [22]. In addition, HDL may be protective 
by reversing cholesterol transport, by inhibiting 
the oxidation of LDL and by neutralizing the 
atherogenic effects of oxidized LDL [23]. The 
supplementation of OFP-EA-extract was effective 
in lowering LDL and raising HDL contents in 
hypercholesterolemic rats.  
 
In fact, the risk of CVD can also be expressed by 
atherogenic index and cardiac risk factor. In this 
study, the elevated atherogenic index and 
cardiac risk factor induced by HFD was 
suppressed significantly by OFP-EA extract (p < 
0.01 at 100 mg/kg and p < 0.001 at 300 mg/kg 
dose respectively). This suggested that OFP-EA 
extract consumption could provide 
atheroscleroprotective effect to the body. 
Although OFP-EA-extract treatment did not 
completely normalized the two indicators in the 
HFD group, the findings were still strong enough 
to demonstrate that OFP-EA-extract possessed 
atheroscleroprotective and cardioprotective 
properties by lowering plasma cholesterol, 
restoring the HDL and improving both 
atherogenic index and cardiac risk factor. It was 
well documented that hypercholesterolemic diet 
could affect the functions of liver substantially 
because of the high-cholesterol condition that 
causes an excessive production of reactive 
oxygen species (ROS), which in turn could 
initiate lipid peroxidation, damage liver functions, 
and affect the cardiovascular system [24-26]. 
 
Non-alcoholic fatty liver disease (NAFLD) is one 
of the most common chronic liver disorders, 
having a broad spectrum ranging from simple 
steatosis to cirrhosis [27-29]. OFP-EA-extract, as 
shown in the current study, exerted beneficial 
effects in reducing the enlargement of liver as 
indicated by a significant decrease in liver lipid 
content in hypercholesterolemic rats.. Therefore, 
the results suggested that OFP-EA-extract may 
have hepatoprotective effects (in terms of 
reducing the risk of developing the condition of 
hepatomegaly and/or fatty liver) by preventing 
the liver from having depositions of fat and 
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cholesterol. The liver is the most important organ 
for the intermediary metabolism of lipids, and 
also manufactures cholesterol for normal body 
functions. Therefore, preventing and treating 
NAFLD are relevant to health promotion. 
Therefore, we studied the effects of OFP-EA-
extract treatment on the cholesterol metabolism-
related gene (HMGR, ACAT and CYP7A1) 
expressions in hypercholesterolemic rats by 
using real-time PCR analysis. HMGR are 
enzymes responsible for cholesterol synthesis, 
whereas ACAT and CYP7A1 are enzymes 
responsible for catalyzing cholesterol 
esterification and bile acid synthesis in 
expending of cholesterol [30]. 
 
It is believed that HMGR are regulated through 
negative feedback of cholesterol [30]. Low 
cholesterol level would trigger HMGR and 
CYP51 transcriptions so as to enhance 
cholesterol synthesis. In this study, the reduced 
transcriptions of these two enzymes in 
hypercholesterolemic rats may be mediated by 
HFD. From our results, the suppressed protein 
expressions of HMGR were observed in the HFD 
fed rats and OFP-EA-extract treatments. There 
was no significant difference of HMGR and 
CYP51 protein levels among all the groups fed 
with HFD and OFP-EA treated animals. Hence, 
the hypocholesterolemic effect exerted by OFP-
EA-extract may not be related to the inhibition of 
cholesterol synthesis. 
 
Excess cholesterol is often stored as cholesteryl 
esters by esterification, and this process is 
catalyzed by the microsomal enzyme, ACAT [31]. 
ACAT in liver is also involved in the synthesis of 
very low density lipoprotein [32]. In the present 
study, the protein expression level of ACAT 
showed a significant increase in all rats with a 
high-cholesterol diet as compared with the 
control group. OFP-EA-extract treatment could 
not alter the increased mRNA expression of 
ACAT in hypercholesterolemic rats, suggesting 
that ACAT was not a target for OFP-EA-extract. 
 
CYP7A1 is a rate-determining enzyme in the 
biosynthetic pathway of bile acids by expending 
cholesterol in liver and is the major cholesterol 
elimination mechanism [31]. The expression level 
of CYP7A1 was shown to be up-regulated by 
high plasma cholesterol, suggesting that the 
synthesis of bile acid is positively dependent on 
plasma cholesterol level [19]. In this study, the 
increased CYP7A1 protein expression in 
hypercholesterolemic rats was attenuated dose 
dependently by OFP-EA-extract treatment. The 
down-regulation of CYP7A1 was most likely an 
outcome instead of a cause of reduced plasma 
cholesterol levels in OFP-EA-extract treated 
animals as plasma cholesterol and CYP7A1 
expression level are positively correlated. 
 
PPARs are members of the nuclear receptor 
superfamily of ligand-binding transcription factors 
that have important effects on lipid homeostasis 
through the regulation of the expression of genes 
involved in lipid metabolism. PPAR-α is 
predominantly expressed in the liver and 
regulates the transcription of genes involved in 
hepatic fatty acid uptake and oxidation [33,34]. , 
and agonists of PPAR-α are shown to be anti-
hyperlipidemic agents [35].  PPAR-α mRNA 
expression was positively correlated with dietary 
fat intake in rats because an increased supply of 
fatty acids, endogenous ligand for PPAR-α 
receptor, might contribute to an increased PPAR-
α signaling and up-regulated PPAR-α mRNA 
expression [36].  In the current experimental 
settings, hypercholesterolemic rats showed an 
up-regulation of PPAR-α mRNA expression. This 
might be due to the extra 5.5% oil in the diet, 
which provided more fatty acids to stimulate 
PPAR-α receptors in the liver. The further up-
regulation of PPAR-α mRNA expression in 
animals consuming OFP-EA-extract could 
explain the hypocholesterolemic effect of OFP-
EA-extract.  
 
One of the most extensively studied phenolic 
compounds in olives is hydroxytyrosol, an o-
diphenol with marked antioxidant activity. 
Hydroxytyrosol shows a broad spectrum of 
beneficial effects such as cancer 
chemoprevention, cardioprotection, skin photo-
protection and anti-inflammatory activity [14-16]. 
Experimental studies also showed that purified 
hydroxytyrosol from olive mill waste possess 
antioxidant effects in alloxan-induced diabetic 
rats by increasing endogenous antioxidant 
enzymes and decreasing plasma thiobarbituric 
acid reactive substances [37]. These biological 
properties are based on scavenging of reactive 
oxygen species by hydroxytyrosol, being more 
active than antioxidant vitamins and synthetic 
antioxidants [37]. In our present study, HPLC 
fingerprinting analysis of OFP-EA extract 
revealed hydroxytyrosol as one of the major 
active constituent. Therefore the potent 
antioxidant polyphenolic compounds such as 
hydroxytyrosol present in OFP-EA extract might 
also help in synergizing the hypocholesterolemic 




The present results indicate for the first time that 
supplementation of OFP-EA-extract has 
significant hypocholesterolemic and hepatopro-
tective effects. Increase in fatty acids unitization 
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in liver of rats fed with high-fat diet and the up-
regulation of PPAR-α expression might probably 
be the mechanism. Further the anti-oxidant 
compounds present in OFP-EA extract might 
also synergistically act to enhance the 
hypocholesterolemic and hepatoprotective 
activities. Therefore, dietary consumption of 
OFP-EA could have beneficial impact on 
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